Do Carbs Build Muscle? What the 2026 Meta-Analysis Actually Found

Henselmans, Vårvik & Izquierdo published a systematic review and meta-analysis in Sports Medicine in 2026 (volume 56, pages 691–702) asking whether higher carbohydrate intake independently enhances muscle hypertrophy during resistance training when protein and training are matched. The search aggregated randomized controlled trials from MEDLINE, SPORTDiscus, SciELO, and Google Scholar through June 2025, comparing higher vs. lower carb intake with muscle size as the outcome. The pooled estimate did not show a statistically meaningful additional hypertrophy benefit from raising carbohydrate intake when protein and training stimulus were equalized between groups. The authors rate the certainty of evidence as low, primarily because energy balance was not strictly controlled across included trials.

That finding does not say carbs are useless. It says that, holding protein and training constant, the carb-intake number is a smaller direct hypertrophy lever than common nutrition advice has long implied. The earlier Henselmans systematic review on carbohydrate intake and resistance training performance (Nutrients 2022) reached a parallel conclusion for strength outcomes — most trials showed no meaningful long-term strength advantage from higher carbohydrate intake when protein was matched, with two outlier studies in either direction. The two reviews together support the same picture from two angles: when the other variables are dialed in, carbohydrate intake is not the primary lever for either size or strength adaptations.

The mechanism story makes this less surprising than it sounds. Carbohydrates do not provide a direct anabolic signal in the way the resistance training stimulus and dietary protein do. Muscle protein synthesis is driven primarily by mechanical tension and amino acid availability — specifically leucine signaling through mTORC1. Insulin response to a carbohydrate load is permissive for muscle protein synthesis in the short term, but at clinically relevant protein intakes the synthetic stimulus is already saturated by the protein meal itself. Adding more carbohydrate around the workout does not meaningfully add to the synthesis response in trials that control for total calories and protein.

Where carbohydrates do earn their place is performance, recovery, and adherence. The 2022 Henselmans performance review documented that higher carbohydrate availability supports session volume and time-to-fatigue, particularly in longer or higher-volume protocols. Multi-set, multi-exercise sessions deplete muscle glycogen meaningfully — heavy compound work in the 5–12 rep range can reduce glycogen 30–40% per session. Restoring glycogen between sessions matters more when the same muscle groups are trained two or three times per week. Adequate carbohydrate intake also makes a calorie surplus easier to sustain, which is a real-world factor in whether a bulk actually delivers the additional bodyweight that supports new strength and size.

Practically, this changes priority order, not target numbers. Total calorie intake remains the primary nutritional input — a 200–500 calorie surplus above maintenance supports lean mass gain at a reasonable rate. Total protein intake remains the second lever — 1.6–2.2 g/kg bodyweight per day covers the evidence-based range for trained lifters, with diminishing returns above 2.2 g/kg. Once those two are set, carbohydrate intake should be chosen to support training quality and a comfortable calorie target. For most lifters training 3–5 days per week, a carb intake of 3–6 g/kg per day delivers both training fuel and a sustainable surplus. Going lower works for lifters who tolerate it without losing session quality; going higher works when adherence or training intensity benefit. The 2026 meta-analysis suggests the size outcome will be similar either way, as long as protein and calories are held to target.

A caveat on certainty. The authors flag low certainty of evidence and recommend stricter energy-balance control and direct morphological assessment (DEXA, ultrasound, MRI) in future trials. Most of the included studies used body composition methods of varying precision, and the carb-vs-calorie disentangling is harder than it sounds — raising carbs typically raises calories unless the protocol explicitly compensates. The conclusion that "carbs do not independently drive hypertrophy" rests on the trials that did equalize protein and training, but the methodological wishlist is real. The strongest tactical read is to treat carb intake as flexible within the 3–6 g/kg range and not chase a precise number.

The takeaway is not "carbs do not matter" — it is that the order of operations matters. Calories first, protein second, training stimulus is the actual driver of hypertrophy, and carbohydrate intake fills the remaining calorie space in whatever ratio supports training and adherence. Get the first three right and the carb number takes care of itself. Lifters who have been chasing a specific carb percentage as if it were the hypertrophy lever can redirect that attention to the variables that controlled trials show actually move the outcome.